Lilly Settles Scores Of Zyprexa Suits

Law360, New York (June 12, 2007, 12:00 AM EDT) -- Eli Lilly & Co. has settled an additional 900 lawsuits surrounding its controversial anti-psychotic drug Zyprexa, a day after a judge denied the pharmaceutical giant's motion for summary judgment in three suits in the multidistrict product liability litigation.

The Indianapolis-based company revealed the settlement on Tuesday, marking the latest in a series of rapprochements reached in the thousands of cases involving Zyprexa, a medication used to treat schizophrenia and bipolar disorder.

For the past two years, Lilly has been under attack over the drug and its...
To view the full article, register now.